Tylenol maker rebounds a day after Trump's unfounded claims about its safety
The White House is reportedly planning to link Tylenol use during pregnancy to autism. The news pushed Kenvue stock down as much as 10%.
← Back to stories
National18 articles from 12 sources across the spectrum· Updated 371d ago
8 across the spectrum · tap a section to jump
The story so far
2 developments- Sep 22, 2025Tylenol maker Kenvue plunges on reports the White House plans to link the drug to autism
- Sep 23, 2025Tylenol maker rebounds a day after Trump's unfounded claims about its safety
Who covered each development
Left
Center
Right
No new developments
Quiet for 371 daysLast development · Sep 23, 2025 — Tylenol maker rebounds a day after Trump's unfounded claims about its safety
How each side is putting it
Left
2 viewpointsCenter
5 viewpointsTylenol maker rebounds a day after Trump’s unfounded claims about its safety - Boston News, Weather, Sports
Ran by 8 outlets· ABC 11 Raleigh, ABC 7 Los Angeles, +6 more
Ran by 1 outlet· Forbes
Right
1 viewpointTylenol maker rebounds a day after Trump's unfounded claims about its safety
Tylenol-maker Kenvue’s stock has lost a quarter of its value in 6 months as momentum grows for autism link despite repeated denials